Establishment Labs(US:ESTA) Financial Modeling Prep·2025-11-07 05:12Core Insights - Establishment Labs Holdings Inc. is a key player in the medical technology sector, focusing on women's health, particularly breast aesthetics and reconstruction, with a price target of $70 set by Needham on November 6, 2025, indicating a potential increase of 7.84% from the current stock price of $64.91 [1] Financial Performance - The Q3 2025 earnings call revealed a quarterly loss of $0.38 per share, which was better than the Zacks Consensus Estimate of a $0.54 loss, resulting in a positive surprise of 29.63% [2][6] - Revenue for Q3 2025 was reported at $53.78 million, exceeding the Zacks Consensus Estimate by 3.45% and showing significant growth from $40.23 million in the same period last year, driven by Motiva product sales contributing $11.9 million [3][6] Market Position - Despite only exceeding consensus revenue estimates once in the last four quarters, the company demonstrated a 33.8% increase in revenue year-over-year, indicating strong market position and growth potential [4] - The stock has shown volatility, with a 52-week high of $65.10 and a low of $26.56, and the current market capitalization is approximately $1.88 billion, with a trading volume of 1,341,361 shares [5]